Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with high mortality, poor prognosis, and palliative treatments, due to the rapid upregulation of alternative compensatory pathways and desmoplastic reaction. miRNAs, small non-coding RNAs, have been recently identified as key player...

Descripción completa

Detalles Bibliográficos
Autores principales: Natesh, Nagabhishek Sirpu, White, Brianna M., Bennett, Maia M. C., Uz, Metin, Kalari Kandy, Rakhee Rathnam, Batra, Surinder K., Mallapragada, Surya K., Rachagani, Satyanarayana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707074/
https://www.ncbi.nlm.nih.gov/pubmed/34959269
http://dx.doi.org/10.3390/pharmaceutics13121987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707074/
https://www.ncbi.nlm.nih.gov/pubmed/34959269
http://dx.doi.org/10.3390/pharmaceutics13121987

Ejemplares similares